JUN 28, 2016 9:35 AM PDT

MAPS: A Novel Protein Quality Control Pathway

WRITTEN BY: Cassidy Reich
Protein quality control (PQC) is incredibly important for cellular health and viability. It is critical for cell survival that any protein that is no longer needed or somehow becomes misfolded is properly disposed of. If there is a buildup of misfolded proteins in the cell, the misfolded proteins can aggregate and impair other cellular processes and they can also grab other functional proteins and inactivate them. Because PQC is such an important factor in cellular health, there are multiple pathways dedicated to handling the problem of quality control. Misfolded proteins can be sequestered from other proteins in the cell, can be refolded properly with the assistance of chaperone proteins, or, if the misfolded proteins have aggregated, chaperone proteins can break up the aggregates. But the most important PQC mechanism is the ubiquitin-proteasome pathway. Misfolded proteins are tagged with long chains of ubiquitin which targets the protein-ubiquitin to the proteasome for degradation.
                                                                        Comparison of the Ub-proteasome system and the MAPS pathway.
The ubiquitin-proteasome pathway requires many different types of enzymes and one such enzyme is the class of deubiquitylases which remove ubiquitin from proteins. The human genome encodes ~100 different deubiquitylases, but only one of these enzymes is localized to the endoplasmic reticulum (ER) membrane. This special deubiquitylase, USP19, is the key to a novel protein quality control pathway called misfolding-associated protein secretion (MAPS).

A recent, very thorough paper published in Nature Cell Biology details this new, previously unheard of mechanism. The MAPS pathway is specific for misfolded proteins and also starts to provide an explanation for the evidence that misfolded proteins in neurodegenerative diseases spread from neuron to neuron in a prion-like manner.

USP19 is a deubiquitylase that is anchored in the ER membrane. >99% of late endosomes form a tight association with the ER membrane as well. In the MAPS pathway, USP19 specifically recruits misfolded proteins with defective ubiquitin signals to the ER membrane where it removes the defective ubiquitin chain and facilitates the transfer of the misfolded protein cargo to the late endosome. The late endosome then moves up to the cell membrane, fuses with the membrane, and releases its cargo of misfolded proteins into the extracellular space.
                                                                              
The researchers, lead by Yihong Ye from the NIH in Bethesda, performed most of their experiments using human embryonic kidney (HEK) cells and green fluorescent protein (GFP), but there is a lot of excitement about how the MAPS pathway applies to neurodegeneration.

Specifically, proteasome dysfunction is an early sign of neurodegenerative diseases and the MAPS pathway really comes into play when the proteasome system is compromised. The theory is the the buildup of misfolded proteins over many, many years puts strain on the ubiquitin-proteasome system, pushing more misfolded proteins to be excreted through the MAPS pathway. Once the proteins are secreted, they can be taken up by other neurons, propagating the spread of these misfolded proteins.

This really is a theory because the MAPS pathway has not been investigated in neurons yet. However, the researchers wanted to get the ball rolling on this line of inquiry so they looked at α-synuclein and the MAPS pathway. They showed that, in HEK cells, misfolded α-synuclein with known Parkinson’s disease mutations is secreted from cells through the MAPS pathway. That means that the MAPS pathway, should it translates to neurons, could be a potential therapeutic target for Parkinson’s disease.  

Sources: AlzForum and Nature Cell Biology
About the Author
  • Cassidy is a curious person, and her curiosity has led her to pursue a PhD in Pharmacology at the New York University Sackler Institute of Biomedical Sciences. She likes to talk about science way too much, so now she's going to try writing about it.
You May Also Like
DEC 25, 2020
Genetics & Genomics
An Improved Reference Genome for Better Research
DEC 25, 2020
An Improved Reference Genome for Better Research
In scientific research, it's crucial to make comparisons. Therefore, reliable standards and controls are essential for d ...
JAN 03, 2021
Cell & Molecular Biology
Gaining Insight Into the Neuronal Circuitry of the Developing Brain
JAN 03, 2021
Gaining Insight Into the Neuronal Circuitry of the Developing Brain
The neuronal connections in the human brain are more complex than anything we can build artificially right now. But rese ...
JAN 04, 2021
Cannabis Sciences
How Does Cannabis Affect the Liver?
JAN 04, 2021
How Does Cannabis Affect the Liver?
As research on cannabis emerges, what we know about how it interacts with the liver is becoming more and more complex. A ...
JAN 05, 2021
Drug Discovery & Development
Promising Epigenetic Treatment for Depression Works After One Dose
JAN 05, 2021
Promising Epigenetic Treatment for Depression Works After One Dose
Researchers affiliated with the University of Sao Paulo in Brazil have used epigenetic modulators to reduce stress-induc ...
JAN 12, 2021
Cell & Molecular Biology
Hyperactive Mitochondria Can Fuel Brain Tumors
JAN 12, 2021
Hyperactive Mitochondria Can Fuel Brain Tumors
The most common and deadly form of brain cancer is known as glioblastoma; the median survival time for patients is only ...
FEB 22, 2021
Microbiology
A Nasal Spray That Seems to Prevent the Spread of COVID-19
FEB 22, 2021
A Nasal Spray That Seems to Prevent the Spread of COVID-19
Reporting in Science, researchers have created an antiviral nasal spray that could help us get the COVID-19 pandemic und ...
Loading Comments...